Shenuo Medical Files Hong Kong IPO Application, Aims for A+H Dual Listing

According to Hong Kong Exchanges and Clearing Limited disclosures, Shenuo Medical (688108.SH), a medical device maker already listed on Shanghai's STAR Market since October 2019, recently submitted its Hong Kong main board IPO application with China Bohai Bank International as sole sponsor. The company aims to establish an A+H dual-listing structure to expand financing channels and boost international market presence. As of July 7, 2026, its A-share market value stands at approximately 7.4 billion yuan. In 2025, Shenuo Medical achieved a turnaround to profitability with annual revenue of 525 million yuan and net profit of 47.5 million yuan, up from losses in prior years, driven by higher-margin products and improved scale efficiency.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments